Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Solve supply chain challenges for (Z)-2-acetylaminocinnamic acid methyl ester with 68%+ yield, 99%+ purity, and no column chromatography. Industrial-scale production ready.
Solve 1,2,4-triazine synthesis challenges with air-ambient, metal-free method. 82-87% yields, no heavy metals, scalable to 100MT. Reduce supply chain risks.
Discover how visible light photocatalysis enables safer, higher-yield synthesis of 3-acyl spirotrienones for pharmaceutical intermediates. Reduce supply chain risks.
Eliminate metal catalysts and inert gas requirements in quinoline synthesis. Our CDMO expertise ensures scalable, green production for antimalarial drugs and PDE4 inhibitors.
Solve heavy metal contamination in 2-trifluoromethyl quinoline synthesis. Our metal-free, air-stable process cuts costs & ensures GMP compliance for drug development.
Discover a 75-96% yield, room-temperature synthesis of 1,3,4-oxadiazole derivatives. Eliminate metal residues and toxic reagents for safer, cost-effective API manufacturing.
Avoid heavy metal catalysts and anhydrous conditions in pyrido[1,2-a][1,3,5]-triazin-4-one synthesis. Reduce production costs and supply chain risks with this scalable, high-yield method.
Discover scalable chiral indolinopyrrole synthesis with 99% ee and 90%+ yield. Ideal for oncology drug development. Reduce costs and supply chain risks.
Discover scalable 2,6-dibromo-4-methylpyridine production with 68.5% yield and 99.5% purity. Eliminate column chromatography and reduce costs for pharmaceutical intermediates.
Discover how advanced cuprous bromide activation and palladium-catalyzed hydrogenation reduce solid waste by 90% while achieving 99.8% purity and 72% yield for AZD9291 production.
Solve axial chiral synthesis challenges with high-yield, mild-condition process. Reduce R&D costs and supply chain risks for asymmetric catalysts.
Solve 4-aryl-NH-1,2,3-triazole synthesis challenges with this metal-free, one-pot method. Achieve 40-75% yields using stable aldehyde bisulfite adducts. Reduce production costs and supply chain risks for pharmaceutical intermediates.
Discover a cost-effective, metal-free synthesis method for 3,4,5-trisubstituted 1,2,4-triazoles. Eliminate anhydrous conditions and heavy metal catalysts to reduce production costs and supply chain risks.
Solve supply chain risks in chiral synthesis with this novel protonic acid catalyst. Achieve 98% ee and 96% yield in ruthenium-catalyzed reactions. Contact us for custom synthesis.
Discover copper-catalyzed indole synthesis with 74-90% yields, nitrogen protection, and 110°C mild conditions. Reduce R&D costs and supply chain risks for pharmaceutical intermediates.
Discover how Rh(III)-catalyzed tandem synthesis of 6-amino-5-acyl benzo[a]carbazole reduces production costs and improves yield for pharmaceutical intermediates.
Discover a cost-effective, palladium-free synthesis of Vismodegib with 99% purity. Eliminate anhydrous/oxygen-free requirements and reduce supply chain risks for your oncology projects.
Solve high-cost, low-yield issues in tegrazan intermediate production. New route achieves ≥99% purity with simplified steps and 100kgs+ scale capability.
Reduce supply chain risks with metal-free deracemization process. 90%+ yield, 95% ee, and scalable production for chiral alcohol intermediates.
Discover how metal-free, photo-catalyzed synthesis of perfluoroalkyl benzimidazoloisoquinolinones reduces costs and supply chain risks for pharmaceutical intermediates. Contact us for custom synthesis.